본문 바로가기
KERD
논문KCI 등재

한국 코로나바이러스감염증-19 환자 5,628명의 역학적, 임상적 특성: 전국단위 다기관 관찰 연구

Epidemiological and clinical characteristics of 5,628 patients with coronavirus disease 2019 in South Korea: A nationwide multicenter study

이승원|문성용|연동건
대한 소아알레르기 호흡기학회 (The Korean Academy Of Pediatric Allergy And Respiratory Disease)|2021.07|Allergy Asthma & Respiratory Disease (알레르기 천식 호흡기질환)|제9권 제3호|pp. 136-140|DOI https://doi.org/10.4168/aard.2021.9.3.136

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

COVID-19CharacteristicsEpidemiologyOutcomeSARS-CoV-2
주제분류소아과학

초록

Purpose: There are limited data on the epidemiological and clinical characteristics and outcomes in Korean patients with laboratory-confirmed coronavirus disease 2019 (COVID-19). We aimed to describe the epidemiological and clinical characteristics and outcomes of patients with COVID-19 using the Korean nationwide multicenter database. Methods: In this nationwide multicenter study, we included all confirmed patients of COVID-19 in South Korea from February 1 to April 30, 2020. Subjects were classified into 3 age groups: those at younger than 10 years (children), 10 to 20 years (adolescents), and 20 years or more (adults). Cases were confirmed by laboratory testing using real-time reverse transcriptase-polymerase chain reaction assay and analyzed for epidemiological and clinical features and outcomes. Patents were followed up until April 30, 2020. Results: Of 5,628 patients with COVID-19 (2,320 males [41.2%] and 3,308 females [58.8%]), there were 66 children (1.2%), 206 adolescents (3.7%), and 5,356 adults (95.2%). The common comorbidities were hypertension (1,201, 21.3%), diabetes (691, 12.3%), dementia (224, 4.0%), chronic heart disease (179, 3.2%), cancer (145, 2.6%), and asthma (128, 2.3%). The common presenting symptoms were cough (2,341, 41.6%), sputum (1,619, 28.8%), fever (1,305, 23.2%), headache (967, 17.2%), myalgia (926, 16.5%), and pharyngodynia (881, 15.7%). One hundred sixty-five patients (2.1%) were confirmed as having moderate or severe COVID-19 and 118 (2.1%) as having severe COVID-19. Conclusion: Our descriptive study provides the epidemiological and clinical characteristics and outcomes of patients with laboratory-confirmed COVID-19 in South Korea.

Abstract

Purpose: There are limited data on the epidemiological and clinical characteristics and outcomes in Korean patients with laboratory-confirmed coronavirus disease 2019 (COVID-19). We aimed to describe the epidemiological and clinical characteristics and outcomes of patients with COVID-19 using the Korean nationwide multicenter database. Methods: In this nationwide multicenter study, we included all confirmed patients of COVID-19 in South Korea from February 1 to April 30, 2020. Subjects were classified into 3 age groups: those at younger than 10 years (children), 10 to 20 years (adolescents), and 20 years or more (adults). Cases were confirmed by laboratory testing using real-time reverse transcriptase-polymerase chain reaction assay and analyzed for epidemiological and clinical features and outcomes. Patents were followed up until April 30, 2020. Results: Of 5,628 patients with COVID-19 (2,320 males [41.2%] and 3,308 females [58.8%]), there were 66 children (1.2%), 206 adolescents (3.7%), and 5,356 adults (95.2%). The common comorbidities were hypertension (1,201, 21.3%), diabetes (691, 12.3%), dementia (224, 4.0%), chronic heart disease (179, 3.2%), cancer (145, 2.6%), and asthma (128, 2.3%). The common presenting symptoms were cough (2,341, 41.6%), sputum (1,619, 28.8%), fever (1,305, 23.2%), headache (967, 17.2%), myalgia (926, 16.5%), and pharyngodynia (881, 15.7%). One hundred sixty-five patients (2.1%) were confirmed as having moderate or severe COVID-19 and 118 (2.1%) as having severe COVID-19. Conclusion: Our descriptive study provides the epidemiological and clinical characteristics and outcomes of patients with laboratory-confirmed COVID-19 in South Korea.

참고문헌 (21)

  1. Lee SW, "Nationwide results of COVID-19 contact tracing in South Korea : individual participant data from an epidemiological survey", JMIR Med Inform, 8, pp.e20992~ (2020)
  2. 최성호, "코로나19 유행의 방역", 대한내과학회지, 95(3), pp.134~140 (2020), 대한내과학회[DOI]
  3. Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area", JAMA, 323, pp.2052~2059 (2020)
  4. Grasselli G, "Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy", JAMA, 323, pp.1574~1581 (2020)
  5. Xie J, "Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China", JAMA Netw Open, 3, pp.e205619~ (2020)
  6. Korea Disease Control and Prevention Agency, "69 Dedicated COVID-19 hospitals", Korea Disease Control and Prevention Agency, ~ (2020)
  7. Yang JM, "Allergic disorders and susceptibility to and severity of COVID-19 : a nationwide cohort study", J Allergy Clin Immunol, 146, pp.790~798 (2020)
  8. Lee SW, "Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching", Gut, 70, pp.76~84 (2021)
  9. Bae SH, "Asymptomatic transmission of SARS-CoV-2 on evacuation flight", Emerg Infect Dis, 26, pp.2705~2708 (2020)
  10. Lee SW, "Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea : a nationwide cohort study", Lancet Psychiatry, 7, pp.1025~1031 (2020)
  11. Woo A, "Incidence of cancer after asthma development : 2 independent population-based cohort studies", J Allergy Clin Immunol, 147, pp.135~143 (2021)
  12. Ha Jihyun, "Ten-Year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017", Clinical and Experimental Pediatrics, 63(7), pp.278~283 (2020), 대한소아청소년과학회[DOI]
  13. Guan WJ, "Comorbidity and its impact on 1590 patients with COVID-19 in China : a nationwide analysis", Eur Respir J, 55, pp.2000547~ (2020)
  14. Chen J, "COVID-19 infection : the China and Italy perspectives", Cell Death Dis, 11, pp.438~ (2020)
  15. Grifoni A, "Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals", Cell, 181, pp.1489~1501 (2020)
  16. Jackson DJ, "Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2", J Allergy Clin Immunol, 146, pp.203~206 (2020)
  17. Reynolds HR, "Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19", N Engl J Med, 382, pp.2441~2448 (2020)
  18. Zhu Z, "Association of asthma and its genetic predisposition with the risk of severe COVID-19", J Allergy Clin Immunol, 146, pp.327~329 (2020)
  19. Koh HY, "Serum heavy metal levels are associated with asthma, allergic rhinitis, atopic dermatitis, allergic multimorbidity, and airflow obstruction", J Allergy Clin Immunol Pract, 7, pp.2912~2915 (2019)
  20. Yon DK, "Serum lipid levels are associated with allergic rhinitis, nasal symptoms, peripheral olfactory function, and nasal airway patency in children", Allergy, 73, pp.1905~1908 (2018)
  21. Kimura H, "Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells", J Allergy Clin Immunol, 146, pp.80~88 (2020)

관련 논문AI추천

한국 코로나바이러스감염증-19 환자의 특성과 경과; 국가 데이터베이스의 분석김상헌대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2021 · 제9권 제3호코로나바이러스감염병-19 초기 유행의 임상 역학적 특성허중연대한내과학회 · 대한내과학회지2020 · 제95권 제2호Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study신경철, 안준홍, 이관호, 이원화, 장종걸, 정진홍, 진현정, 최은영, 홍경수연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제5호Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea기모란한국역학회 · Epidemiology and Health2020 · 제42권 코로나바이러스감염증-19(SARS-CoV-2 감염증)의 임상 양상과 치료이신원대한이비인후과학회 부산,울산,경남 지부회 · 임상이비인후과2020 · 제31권 제2호The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients신은경, 최효영, Hayes Neil한국역학회 · Epidemiology and Health2021 · 제43권

이 간행물의 다른 논문 (10건)

한국 코로나바이러스감염증-19 환자의 특성과 경과; 국가 데이터베이스의 분석김상헌pp. 113-114Severe acute respiratory syndrome coronavirus-2 대유행 중 알레르기 환자의 진료장재혁, 박해심, 이영수pp. 115-123코로나바이러스감염증-19 (coronavirus disease 2019) 백신과 이상 반응정은희pp. 124-135소아의 메타콜린 기관지유발검사에서 PC20-FEF25%-75% 및 △FVC에 대한 분석김현아, 현명철, 김동섭, 최재영, 안지영, 최봉석, 박숙현, 권정은pp. 141-147천식 및 알레르기비염으로 진단된 소아, 청소년 및 성인에서의 흡입 알레르겐에 대한 감작률 비교최길순, 이나겸, 김희규pp. 148-155
원문 보기